Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 375 results for "biocon"

Biocon : to enter Europe to cut West Asia risk

Mumbai : Biopharma company Biocon on Wednesday said that it is looking at entering new markets such as Latin America , Eastern Europe and Southeast Asia to mitigate the risk associated with the Middle East and North African markets (MENA). Kiran ... 4 Traders, 10 hours ago

15 images for biocon

India TV, 2 days ago
Financial Express, 2 days ago
Sify, 1 day ago
Money Today, 2 days ago
Sify, 2 days ago
Oneindia, 2 days ago
Money Control, 2 days ago, 2 days ago
New Indian Express, 1 week ago
New Indian Express, 1 week ago
Business Standard

Biocon Q2 net profit flat

Comment · print · T T T+· T- Biopharma segment hits profit Kiran Mazumdar Shaw. File photo: G.R.N. Somashekar TOPICS Biocon on Wednesday reported a flat growth in its net profit at Rs.102 crore against the same period last year. ...
 The Hindu1 day ago Biocon Q2 net at Rs 102 cr  The Statesman2 days ago Confident that clinical trials climate will improve in next six months: Kiran Mazumdar-Shaw, Biocon  Financial Express2 days ago Biocon's net profit remains flat at Rs.102 cr in Q2  PharmaBiz2 days ago

Biocon to tap emerging markets to ensure growth

Biocon Limited, which announced its Q2 FY15 results on Tuesday, said despite many states offering sops for attracting investments, it's open to setting up projects in Karnataka. Kiran Mazumdar-Shaw, chairperson and managing director shared some of the plans and strategies of the company with Praveen Bose. Excerpts: What is the update on Syngene’s listing? We are focussed on a well-worked out strategic plan for Syngene which will lead to an initial public offering (IPO) and listing in ...
 Rediff.com1 day ago We are in process of expansion in Karnataka: Kiran Mazumdar-Shaw  Business Standard2 days ago Biocon to spur global growth from Emerging Markets as MENA region throws up credit risk challenges  PharmaBiz2 days ago NPPA's unilateral stand-off unhealthy for sector: Biocon  Money Control2 months ago
Business Standard

Biocon: Muted quarter, lacks immediate triggers

Biocon's September quarter results were below estimates, with revenues growing 2.26% over the year-ago quarter to Rs 757 crore on the back of a muted performance of its biopharmaceutical (biopharma) segment. Sales in the segment, which accounts for 74% of ...
 Business Standard1 day ago

Biocon shares fall after July-Sept earnings

10:35am IST Reuters Market Eye - Biocon Ltd ( BION.NS ) falls 2.7 percent. July-Sept earnings lag some analyst estimates. Margins contracted by 90 bps to 22.8 percent are on account of higher employee costs. Biocon says biopharma business ...
 Reuters India2 days ago Biocon shares fall after July-September earnings  Economic Times2 days ago African rivalries weaken U.N. hand against rebels in Congo  Yahoo! Maktoob News2 days ago
Business Today India

Biocon reports flat growth in Q2, net at Rs 102 crore

Biocon Chairman and Managing Director Kiran Mazumdar-Shaw (Photo: Reuters) Biocon has reported a flat growth in its consolidated net profit at Rs 102.05 crore for the quarter ended September 30, 2014. The company had posted a net profit after ...
 Business Today India2 days ago CPhI: Biocon will add 'multifold capacity' as it powers into biosimilars  FiercePharmaManufacturing2 weeks ago Only four women among India's 100 richest  Rediff.com4 weeks ago India's 100 richest includes only four women  Deccan Chronicle4 weeks ago
Times of India

Biocon profit flat, revenue up 3%

BANGALORE: Biopharma major Biocon's net profit for the quarter ended September was flat at Rs 102 crore, compared to the corresponding quarter last year. Total revenue rose just 3%, to Rs 773 crore. The results disappointed the stock market; on ...
 Times of India2 days ago BIOCON : profit flat, revenue up 3%  4 Traders8 hours ago

Biocon posts Rs 773 crores revenue in Q2 FY15

Branded formulations records strong growth of 17 per cent Biocon has recently posted the Q2 FY15 results. The biopharma segment recorded revenues of Rs 442 crores in Q2FY15. The biopharma business continues to be impacted by various factors like ...
 Express Pharma2 days ago BIOCON : Q2 FY15 Revenues at Rs 773 Crore, PAT at Rs 102 Crore...  4 Traders3 days ago Biocon Q2 FY15 Revenues at Rs 773 Crore, PAT at Rs 102 Crore  AndhraNews.net19 hours ago Biocon Q2 FY15 Revenues at 773 Crore, PAT at 102 Crore [Global Data Point]  Pharmacy Choice2 days ago

Biocon reports marginal fall in Q2 consolidated net profit

. The company has registered 90.23% rise in its net profit at Rs 181.52 crore for the quarter under review as compared to Rs 95.42 crore for the same quarter in the previous year. Total income of the company has increased 17.57% at Rs 681.57 crore ...
 Indian-Commodity2 days ago Biocon consolidated net profit declines 0.10% in the September 2014 quarter  HDFC Securities2 days ago Biocon standalone net profit rises 90.23% in the September 2014 quarter  HDFC Securities2 days ago

Top10: Stocks to focus on October 22

Here are Top 10 stocks to focus on October 22 – Cairn India, Federal Bank, CESC, Biocon, KPIT Tech, Mcleod Russel, DHFL, Guj Fluoro, BASF, Mangalore Chemicals.
 Money Control2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - biocon
Get updated on latest news & your favorite topics right in your inbox!
More     Less